Dynamic immune response and its influencing factors in COVID-19 patients with non-alcoholic fatty liver disease: A cohort study

Figure 6 Impact of body mass index on lymphocyte subsets and their percentages in coronavirus disease 2019 patients with non-alcoholic fatty liver disease: A longitudinal analysis from hospital admission to 4 weeks post-discharge. A: Lymphocyte subset counts (cells/μL); B: Lymphocyte subset percentages (%). ^aP < 0.05, normal weight vs overweight; ^bP < 0.05, normal weight vs obesity; ^cP < 0.05, overweight vs obesity; ^dP < 0.05; ^eP < 0.01; ^fP < 0.001. Normal weight: 18.5 ≤ body mass index (BMI) < 24; Overweight: 24 ≤ BMI < 28; Obesity: BMI ≥ 28; LY: Lymphocyte counts.